Results 151 to 160 of about 53,302 (297)

Microbial Safety of Legumes—A Review: Bacterial Contamination, Foodborne Outbreaks, and Traditional and Innovative Mitigation Strategies

Legume Science, Volume 8, Issue 2, June 2026.
ABSTRACT Demand for plant‐based foods, including legumes, is growing as a result of consumer preferences shifting toward food sustainability and plant‐based, protein‐rich foods. However, to ensure the food safety of such alternatives, assessing the prevalence of foodborne pathogens related to these products is critical, especially with their increasing
Natoavina T. Faliarizao, Narindra Randriamiarintsoa, Teresa M. Bergholz, Kirk D. Dolan   +3 more
wiley   +1 more source

Botulinum toxin type E alleviates trigeminal neuropathic pain via modulation of the HIF-1α-NLRP3 pathway. [PDF]

Front Toxicol
Son J, Kim Y, Ju J, Kim J, Nam J, Cha Y, Ahn D.   +6 more
europepmc   +1 more source

Bacteriophages in the Rhizosphere: Roles in Nutrient Cycling, Bacterial Community Structure, and Animal‐Mediated Dispersal

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
This review discusses bacteriophages' roles in soil ecosystems, highlighting their impact on nutrient cycling, plant health, and soil remediation, as well as animal‐mediated phage dispersal mechanisms. Overall, while bacteriophages have potential biotechnological applications, their negative effects on microbial functions and nutrient cycling highlight
Majid Komijani, Hassan Maddahi, Marzieh Rezaei, Mohammad Hussein Abnosi, Abdullah Khalaf Ahmed   +4 more
wiley   +1 more source

Preoperative Botulinum Toxin Type A Use in Giant Inguinal Hernia Repair: A Scoping Review. [PDF]

Med Sci (Basel)
Fernicola A, Ricciardelli L, Cece A, Porcaro F, Parmeggiani D, Santangelo M, Quarto G.   +6 more
europepmc   +1 more source

Encephalopathy: Cause, Pathogenesis, and Treatment

MedComm, Volume 7, Issue 6, June 2026.
Various encephalopathies (sepsis‐associated, hepatic, hypoxic–ischemic, diabetic, uremic, toxic) have incompletely elucidated pathogenesis, which severely restricts targeted therapy development. Small molecule drugs show unique multitarget potential but face toxicity, poor blood–brain barrier penetration and unclear specificity.
Shimeng Lv, Xia Zhong, Ruirui Shang, Linghui Kong, Yufei Huang, Yuexiang Ma, Jing Teng, Sheng Wei   +7 more
wiley   +1 more source

Botulinum Toxin Type A as an Early Intervention for Traumatic Oculomotor Nerve Palsy: A Pediatric Case Report. [PDF]

Cureus
Koiwa C, Negishi T, Ito M, Noda E, Nakao S.   +4 more
europepmc   +1 more source

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

Movement Disorders Clinical Practice, Volume 13, Issue 6, Page 1383-1398, June 2026.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan, Seyed‐Mohammad Fereshtehnejad, Christos Ganos, Emily Swinkin, Anthony E. Lang   +4 more
wiley   +1 more source

Botulinum Toxin Type A Injections in the Bladder Wall-An Effective Treatment for Urinary Incontinence with Low Long-Term Adherence. [PDF]

Toxins (Basel)
Cruz F, Michel MC, Igawa Y.
europepmc   +1 more source

Putamen Atrophy as a Predictive Factor of Efficacy of GPi‐DBS in Dystonia‐Dyskinesia Syndrome Secondary to Perinatal Anoxic Encephalopathy

Movement Disorders, Volume 41, Issue 6, Page 1402-1412, June 2026.
Abstract Background Perinatal hypoxic–ischemic encephalopathy (HIE) is a severe condition resulting from impaired oxygen delivery to the developing brain, often leading to both motor deficits and dystonia‐dyskinetic syndromes (DDS). In selected cases, deep brain stimulation of the globus pallidus internus (GPi‐DBS) may provide a therapeutic option ...
Marylou Grasso, Pierre‐Olivier Moser, Sidonie Sauvageot, Valérie Gil, Emilie Chan‐Seng, Emily Sanrey, Philippe Coubes, Gaëtan Poulen   +7 more
wiley   +1 more source

Beyond Conventional Analgesics: Updated Evidence Supporting Botulinum Toxin Type A for-Neuralgia Management. [PDF]

Int J Med Sci
Yu JT, Li CP, Huang TM, Tsai RY.
europepmc   +1 more source